Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review, Eur Respir J. sept, vol.46, issue.3, pp.795-806, 2015. ,
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management, Am J Respir Crit Care Med. 15 mars, vol.183, issue.6, pp.788-824, 2011. ,
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline, Am J Respir Crit Care Med. 1 sept, vol.198, issue.5, pp.44-68, 2018. ,
Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, Lancet Respir Med. juill, vol.2, issue.7, pp.566-72, 2014. ,
Predicting prognosis in idiopathic pulmonary fibrosis, p.11 ,
Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PloS One. 30 mai, vol.2, p.482, 2007. ,
Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality, Radiology. mars, vol.246, issue.3, pp.935-975, 2008. ,
High-Resolution Computed Tomography in Idiopathic Pulmonary Fibrosis: Diagnosis and Prognosis, Am J Respir Crit Care Med. 15 août, vol.172, issue.4, pp.488-93, 2005. ,
Interobserver Variability in the CT Assessment of Honeycombing in the Lungs, Radiology. mars, vol.266, issue.3, pp.936-980, 2013. ,
Automated Quantitative Computed Tomography Versus Visual Computed Tomography Scoring in Idiopathic Pulmonary Fibrosis: Validation Against Pulmonary Function, J Thorac Imaging. sept, vol.31, issue.5, pp.304-315, 2016. ,
Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures, Eur Respir J. janv, vol.49, issue.1, p.1601011, 2017. ,
Unclassifiable-interstitial lung disease: Outcome prediction using CT and functional indices, Respir Med. sept, vol.130, pp.43-51, 2017. ,
Chronic hypersensitivity pneumonitis: identification of key prognostic determinants using automated CT analysis, BMC Pulm Med, vol.17, issue.2, 2017. ,
,
Pulmonary vascular lesions in end-stage idiopathic pulmonary fibrosis: Histopathologic study on lung explant specimens and correlations with pulmonary hemodynamics, Hum Pathol. janv, vol.38, issue.1, pp.60-65, 2007. ,
Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis, Eur Respir J. mai, vol.47, issue.5, pp.1445-51, 2016. ,
Changes in Clinical and Physiologic Variables Predict Survival in Idiopathic Pulmonary Fibrosis, American Journal of Respiratory and Critical Care Medicine, vol.168, pp.538-542, 2003. ,
Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important Difference, Am J Respir Crit Care Med. 15 déc, vol.184, issue.12, pp.1382-1391, 2011. ,
Prognostic Implications of Physiologic and Radiographic Changes in Idiopathic Interstitial Pneumonia, Am J Respir Crit Care Med. sept, vol.168, issue.5, pp.543-551, 2003. ,
Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed Tomography, American Journal of Respiratory and Critical Care Medicine, vol.167, pp.962-969, 2003. ,
Interstitial vascularity in fibrosing alveolitis, Am J Respir Crit Care Med. 1 févr, vol.167, issue.3, pp.438-481, 2003. ,
Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med. 1 juin, vol.169, issue.11, pp.1203-1211, 2004. ,
Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis, Am J Respir Crit Care Med. 1 août, vol.170, issue.3, pp.242-51, 2004. ,
CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension, Thorax, vol.71, pp.830-837, 2016. ,
Quantitative CT Measurement of Cross-sectional Area of Small Pulmonary Vessel in COPD, Academic Radiology, vol.17, pp.93-99, 2010. ,
Lung capillary blood volume and membrane diffusion in idiopathic interstitial pneumonia, Respir Med. avr, vol.106, issue.4, pp.564-70, 2012. ,
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial, Lancet Respir Med. 28 août, 2018. ,
Healthrelated quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor, Respir Med. avr, vol.99, issue.4, pp.408-422, 2005. ,
Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test, Am J Respir Crit Care Med, vol.174, issue.7, pp.803-812, 2006. ,
Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia, Am J Respir Crit Care Med, vol.168, issue.9, pp.1084-90, 2003. ,
The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis, Eur Respir J. janv, vol.25, issue.1, pp.96-103, 2005. ,